Details of the Drug Reposition

General Information of This Drug (ID: DM529QO)

Drug Name
pbi-shRNA STMN1   DM529QO
Drug Type
Short hairpin RNA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Breast cancer DIS7DPX1 2C60-2C65 Investigative [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01505153) Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.